icosapent ethyl Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 2 (1)

Interventional (1)

Canadian Medical and Surgical Knowledge Translation Research Group (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadmyalgia

I am/have/hadcough

I am/have/hadSARS

I am/have/hadpharyngitis

I am/have/hadacute respiratory syndrome (sars)

I am/have/hadfever

I am/have/hadsore throat

I am/have/hadcovid-19

I am/have/haddyspnea

added new label for I am/have/had

more

I am looking for

I am looking foricosapent ethyl

I am looking forthroat

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19

This is a 14-day long prospective, multi-site, two-armed, randomized, open-label study that will enroll approximately 100 adult outpatients in Canada who have received a positive SARS-CoV-2 test result within the preceding 72 hours. Participants will be randomized (1:1) to receive either icosapent ethyl (4 g BID for 3 days, then …

myalgia

cough

SARS

pharyngitis

throat

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.